Hyatt shorts hold after Q3 beat, Street lifts targets

H reported Q3 earnings on October 29 and the stock rose 4.2% on the day, yet short sellers have not moved for the exit.

Short interest closed out the week at 13.8% of the free float, up from 13.5% a week earlier and roughly 22% higher than it was a month ago. The build that accumulated in the first two weeks of October, when shorts added close to one million shares in a handful of sessions, is still fully intact. The position has barely shifted since then, which tells you the thesis did not depend on the earnings outcome. Despite the crowded short book, the borrow market offers no mechanical pressure on those positions. Cost to borrow has held near 0.64%, well within its recent range, while availability at 106% of short interest means there are marginally more shares available to lend than are currently borrowed, a comfortable position for anyone who needs to maintain a short. The 52-week low on availability was 55%, so the current reading is not tight by any historical standard.

Options positioning has stayed firmly in call territory throughout the week. The put/call ratio came in at 0.22 on Friday, just above its 20-day average of 0.21 and well below the mid-point of its 52-week range. The skew has not shifted defensively after the earnings release, which aligns with the short book holding rather than covering: short sellers are not being squeezed, and call buyers are not pricing in fresh upside beyond what they already own.

The Street moved in the same direction after the print. Barclays lifted its target from $202 to $207 on Friday, maintaining Overweight, the second time Barclays has raised the target in two weeks. Morgan Stanley had already moved to $224 before the release. JP Morgan and Wells Fargo also hold positive or neutral ratings with targets of $207 and $189 respectively, and the mean analyst target is $199. At a current price of $180.57, the stock trades roughly 10% below the consensus target, a gap that widened slightly after Friday's 2% pullback. Valuation multiples have crept up: the P/E ratio has expanded by about 4.8 points over the past 30 days, now sitting near 39.7x, and EV/EBITDA has climbed to 16.5x. The ORTEX analyst recommendation factor ranks in the 93rd percentile of the universe, reflecting how skewed the coverage is toward buy ratings, while the short score of 73.4 ranks near the bottom 5th percentile for short-score rank, meaning shorts are significant relative to most stocks in the database.

The Pritzker family, which controls a combined stake approaching 40% across various trusts, features prominently on the 13D register. Thomas J. Pritzker last amended his Schedule 13D in January 2026, declaring 22.8% of the class. Several affiliated entities carry their own filings. Baron Capital Group has been the most active institutional buyer, adding over 937,000 shares in the period to September 30, bringing its declared position to 7.7% of shares outstanding. On the insider side, the 90-day net position is a modest sale of 6,715 shares valued at roughly $1.2 million, largely attributable to two pre-planned 10b5-1 disposals by Joan Bottarini. The most significant discretionary insider trade in the record was a cluster of sales by CEO Mark Hoplamazian in late June at prices around $196, before the stock pulled back to current levels.

With the Q3 release now behind it and the next earnings event not scheduled until February 11, the next question for both sides of the trade is whether the short thesis evolves as post-results data comes in, and whether the gap between the current price and mean analyst target narrows or widens further in the weeks ahead.